Smith Asset Management Group LP Has Trimmed Orasure Technologies (OSUR) Stake By $1.95 Million; EPIRUS BIOPHARMACEUTICALS (EPRSQ) Sellers Decreased By 39.23% Their Shorts

November 14, 2017 - By Adrian Erickson

Smith Asset Management Group Lp decreased Orasure Technologies Inc (OSUR) stake by 26.24% reported in 2017Q2 SEC filing. Smith Asset Management Group Lp sold 114,877 shares as Orasure Technologies Inc (OSUR)’s stock rose 29.30%. The Smith Asset Management Group Lp holds 322,987 shares with $5.58 million value, down from 437,864 last quarter. Orasure Technologies Inc now has $869.09M valuation. The stock declined 0.42% or $0.06 reaching $14.33 per share. About shares traded. OraSure Technologies, Inc. (NASDAQ:OSUR) has risen 116.07% since November 14, 2016 and is uptrending. It has outperformed by 99.37% the S&P500.

EPIRUS BIOPHARMACEUTICALS INCORPORATED (OTCMKTS:EPRSQ) had a decrease of 39.23% in short interest. EPRSQ’s SI was 7,900 shares in November as released by FINRA. Its down 39.23% from 13,000 shares previously. With 18,500 avg volume, 0 days are for EPIRUS BIOPHARMACEUTICALS INCORPORATED (OTCMKTS:EPRSQ)’s short sellers to cover EPRSQ’s short positions. It closed at $0.012 lastly. It is down 0.00% since November 14, 2016 and is . It has underperformed by 16.70% the S&P500.

EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company. The company has market cap of $314,210. The Firm focuses on biosimilars, which are biologic drugs. It currently has negative earnings. The Company’s segment is the development and commercialization of biosimilar monoclonal antibodies for emerging markets.

Investors sentiment decreased to 1.16 in 2017 Q2. Its down 0.20, from 1.36 in 2017Q1. It dived, as 16 investors sold OSUR shares while 63 reduced holdings. 38 funds opened positions while 54 raised stakes. 53.38 million shares or 6.53% more from 50.10 million shares in 2017Q1 were reported. Hanseatic Mngmt Serv invested in 0% or 172 shares. Swiss Savings Bank holds 91,400 shares. Strs Ohio stated it has 0% of its portfolio in OraSure Technologies, Inc. (NASDAQ:OSUR). Mckinley Cap Mngmt Llc Delaware invested in 0.21% or 326,980 shares. Morgan Stanley owns 160,041 shares or 0% of their US portfolio. Cornerstone Cap Mngmt Ltd Liability Company has invested 0.03% in OraSure Technologies, Inc. (NASDAQ:OSUR). The Kansas-based Koch has invested 0.06% in OraSure Technologies, Inc. (NASDAQ:OSUR). Creative Planning accumulated 4,316 shares. Paloma Prns Mngmt Co invested in 37,255 shares or 0.01% of the stock. Eam Investors Limited Liability reported 0.84% stake. Plante Moran Financial Advisors Ltd Llc owns 150 shares. Manatuck Hill Prtn Ltd has invested 0.26% in OraSure Technologies, Inc. (NASDAQ:OSUR). Advisory Serv Ntwk Limited Liability Company has 12,913 shares for 0.03% of their portfolio. Columbus Circle Investors owns 338,164 shares or 0.1% of their US portfolio. Raymond James And Assocs holds 0% or 15,305 shares.

Since May 25, 2017, it had 0 insider buys, and 3 sales for $2.18 million activity. Shares for $752,890 were sold by SPAIR RONALD H. $1.33M worth of stock was sold by LANCASTER RONNY B on Thursday, May 25. $100,990 worth of stock was sold by Patrick Charles W on Tuesday, May 30.

Analysts await OraSure Technologies, Inc. (NASDAQ:OSUR) to report earnings on February, 14. They expect $0.09 EPS, down 30.77% or $0.04 from last year’s $0.13 per share. OSUR’s profit will be $5.46 million for 39.81 P/E if the $0.09 EPS becomes a reality. After $0.09 actual EPS reported by OraSure Technologies, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Smith Asset Management Group Lp increased Unilever Nv (NYSE:UN) stake by 6,785 shares to 10,800 valued at $597,000 in 2017Q2. It also upped Travelers Cos Inc (NYSE:TRV) stake by 9,057 shares and now owns 165,769 shares. Adidas Ag (ADDYY) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Twitter Auto Publish Powered By :